Avanos Medical Share Price (NYSE: AVNS)

$11.59

▲

-0.12

(-1.02%)

Live

Last updated on August 26, 2025 at 1:29 AM IST

$₹

Check the interactive Avanos Medical Stock chart to analyse performance

Avanos Medical stock performance

as on August 26, 2025 at 1:29 AM IST

Today's Low:$11.42
Today's High:$11.80
$11.59
1.51%
Downside
Day's Volatility :3.26%
Upside
1.78%
52 Weeks Low:$9.30
52 Weeks High:$25.36
$11.59
19.73%
Downside
52 Weeks Volatility :63.32%
Upside
54.3%

Avanos Medical Stock Returns

Period	Avanos Medical, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-8.52%	6.0%	0.0%
6 Months	-25.08%	-7.2%	0.0%
1 Year	-50.53%	-11.1%	0.0%
3 Years	-54.87%	5.5%	-10.0%

Avanos Medical, Inc. Key Stats

Check Avanos Medical key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$11.71
Open	$11.55
Today's High	$11.8
Today's Low	$11.415
Market Capitalization	$543.4M
Today's Volume	$466.0K
52 Week High	$25.36
52 Week Low	$9.303
Revenue TTM	$692.5M
EBITDA	$88.3M
Earnings Per Share (EPS)	$-10.02
Profit Margin	-66.89%
Quarterly Earnings Growth YOY	-0.37%
Return On Equity TTM	-46.17%

Stock Returns calculator for Avanos Medical Stock including INR - Dollar returns

The Avanos Medical stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Avanos Medical investment value today

Current value as on today

₹53,320

Returns

₹46,680

(-46.68%)

Returns from Avanos Medical Stock

₹51,035 (-51.04%)

Dollar Returns*

₹4,355 (+4.36%)

Indian investors sentiment towards Avanos Medical Stock

29%

Period: Jul 26, 2025 to Aug 25, 2025. Change in 30 Days versus previous period

Search interest for Avanos Medical Stock from India on INDmoney has increased by 29% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Avanos Medical, Inc.

Name
Holdings %
Name
Holdings %
BlackRock Inc
14.86%
Vanguard Group Inc
9.62%
T. Rowe Price Investment Management,Inc.
8.61%
Dimensional Fund Advisors, Inc.
5.56%
Armistice Capital, LLC
4.39%
State Street Corp
4.16%

Analyst Recommendation on Avanos Medical Stock

Rating

Trend

Buy

66%Buy

33%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Avanos Medical(by analysts ranked 0 to 5 stars)

Avanos Medical Share Price Target

What analysts predicted

Upside of 20.79%

Target:

$14.00

Current:

$11.59

Avanos Medical share price target is $14.00, a slight Upside of 20.79% compared to current price of $11.59 as per analysts' prediction.

Avanos Medical Stock Insights

Price Movement
In the last 6 months, AVNS stock has moved down by -24.7%
Increasing Revenue
Revenue is up for the last 2 quarters, 167.5M → 175.0M (in $), with an average increase of 4.3% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 6.6M → -76.8M (in $), with an average decrease of 1263.6% per quarter
AVNS vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 34.1% return, outperforming this stock by 84.5%
AVNS vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 154.1% return, outperforming this stock by 210.8%
Price to Sales
ForAVNS every $1 of sales, investors are willing to pay $0.8, whereas for Boston Scientific Corp., the investors are paying $8.5 for every $1 of sales.

Avanos Medical, Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$697.6M	↑ 6.94%
Net Income	$-45.9M	↓ 179.83%
Net Profit Margin	-6.58%	↓ 15.39%

	FY20	Y/Y Change
Revenue	$714.8M	↑ 2.47%
Net Income	$-27.2M	↓ 40.74%
Net Profit Margin	-3.81%	↑ 2.77%

	FY21	Y/Y Change
Revenue	$587.0M	↓ 17.88%
Net Income	$6.3M	↓ 123.16%
Net Profit Margin	1.07%	↑ 4.88%

	FY22	Y/Y Change
Revenue	$820.0M	↑ 39.69%
Net Income	$50.5M	↑ 701.59%
Net Profit Margin	6.16%	↑ 5.09%

	FY23	Y/Y Change
Revenue	$673.3M	↓ 17.89%
Net Income	$-61.8M	↓ 222.38%
Net Profit Margin	-9.18%	↓ 15.34%

	FY24	Y/Y Change
Revenue	$687.8M	↑ 2.15%
Net Income	$-392.1M	↑ 534.47%
Net Profit Margin	-57.01%	↓ 47.83%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$166.1M	↓ 4.15%
Net Income	$-900.0K	↓ 108.57%
Net Profit Margin	-0.54%	↓ 6.6%

	Q2 FY24	Q/Q Change
Revenue	$171.7M	↑ 3.37%
Net Income	$1.8M	↓ 300.0%
Net Profit Margin	1.05%	↑ 1.59%

	Q3 FY24	Q/Q Change
Revenue	$170.4M	↓ 0.76%
Net Income	$4.3M	↑ 138.89%
Net Profit Margin	2.52%	↑ 1.47%

	Q4 FY24	Q/Q Change
Revenue	$179.6M	↑ 5.4%
Net Income	$-397.3M	↓ 9339.53%
Net Profit Margin	-221.21%	↓ 223.73%

	Q1 FY25	Q/Q Change
Revenue	$167.5M	↓ 6.74%
Net Income	$6.6M	↓ 101.66%
Net Profit Margin	3.94%	↑ 225.15%

	Q2 FY25	Q/Q Change
Revenue	$175.0M	↑ 4.48%
Net Income	$-76.8M	↓ 1263.64%
Net Profit Margin	-43.89%	↓ 47.83%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$402.2M	↑ 2.89%

	FY20	Y/Y Change
Profit	$373.3M	↓ 7.19%

	FY21	Y/Y Change
Profit	$364.3M	↓ 2.41%

	FY22	Y/Y Change
Profit	$450.0M	↑ 23.52%

	FY23	Y/Y Change
Profit	$379.7M	↓ 15.62%

	FY24	Y/Y Change
Profit	$381.3M	↑ 0.42%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$94.8M	↓ 2.67%

	Q2 FY24	Q/Q Change
Profit	$95.6M	↑ 0.84%

	Q3 FY24	Q/Q Change
Profit	$92.9M	↓ 2.82%

	Q4 FY24	Q/Q Change
Profit	$98.0M	↑ 5.49%

	Q1 FY25	Q/Q Change
Profit	$89.8M	↓ 8.37%

	Q2 FY25	Q/Q Change
Profit	$92.1M	↑ 2.56%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-74.5M	↓ 48.83%
Investing Cash Flow	$-108.1M	↓ 116.9%
Financing Cash Flow	$1.5M	↓ 100.46%

	FY20	Y/Y Change
Operating Cash Flow	$-2.5M	↓ 96.64%
Investing Cash Flow	$-24.2M	↓ 77.61%
Financing Cash Flow	$-70.0M	↓ 4766.67%

	FY21	Y/Y Change
Operating Cash Flow	$87.3M	↓ 3592.0%
Investing Cash Flow	$-21.0M	↓ 13.22%
Financing Cash Flow	$-55.3M	↓ 21.0%

	FY22	Y/Y Change
Operating Cash Flow	$90.9M	↑ 4.12%
Investing Cash Flow	$-135.4M	↑ 544.76%
Financing Cash Flow	$56.7M	↓ 202.53%

	FY23	Y/Y Change
Operating Cash Flow	$32.4M	↓ 64.36%
Investing Cash Flow	$21.6M	↓ 115.95%
Financing Cash Flow	$-94.2M	↓ 266.14%

	FY24	Y/Y Change
Operating Cash Flow	$100.7M	↑ 210.8%
Investing Cash Flow	$-27.5M	↓ 227.31%
Financing Cash Flow	$-49.1M	↓ 47.88%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-8.0M	↓ 162.99%
Investing Cash Flow	$-2.0M	↓ 102.47%
Financing Cash Flow	$-700.0K	↓ 99.39%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$27.8M	↓ 447.5%
Investing Cash Flow	$-5.9M	↑ 195.0%
Financing Cash Flow	$-5.0M	↑ 614.29%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$23.0M	↓ 17.27%
Investing Cash Flow	$-12.0M	↑ 103.39%
Financing Cash Flow	$-16.0M	↑ 220.0%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$57.9M	↑ 151.74%
Investing Cash Flow	$-7.6M	↓ 36.67%
Financing Cash Flow	$-27.4M	↑ 71.25%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$25.7M	↓ 55.61%
Investing Cash Flow	$-9.1M	↑ 19.74%
Financing Cash Flow	$-29.1M	↑ 6.2%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$6.8M	↓ 73.54%
Investing Cash Flow	$-13.2M	↑ 45.05%
Financing Cash Flow	$-3.2M	↓ 89.0%

Avanos Medical Technicals Summary

Sell

Neutral

Buy

Avanos Medical is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Avanos Medical, Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Avanos Medical, Inc.	-2.5%	-25.08%	-50.53%	-54.87%	-63.29%
Medtronic Plc	0.8%	2.82%	3.77%	3.67%	-10.92%
Edwards Lifesciences Corp.	4.26%	12.47%	19.03%	-10.31%	0.38%
Boston Scientific Corp.	0.31%	1.71%	33.6%	162.02%	169.81%
Stryker Corporation	-1.61%	1.62%	11.27%	90.44%	108.57%
Abbott Laboratories	4.94%	-1.75%	17.65%	30.12%	28.49%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Avanos Medical, Inc.	33.23	NA	NA	0.8	-0.46	0.02	NA	16.76
Medtronic Plc	25.61	25.61	2.16	5.46	0.1	0.04	0.03	37.46
Edwards Lifesciences Corp.	34.24	34.24	4.89	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	63.2	63.2	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	52.08	52.08	2.24	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.64	16.64	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Avanos Medical, Inc.	Buy	$543.4M	-63.29%	33.23	-66.89%
Medtronic Plc	Buy	$118.8B	-10.92%	25.61	13.63%
Edwards Lifesciences Corp.	Buy	$48.0B	0.38%	34.24	72.96%
Boston Scientific Corp.	Buy	$157.3B	169.81%	63.2	13.55%
Stryker Corporation	Buy	$150.7B	108.57%	52.08	12.25%
Abbott Laboratories	Buy	$230.8B	28.49%	16.64	32.43%

About Avanos Medical, Inc.

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; OrthogenRx knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Organization	Avanos Medical
Employees	2227
CEO	Mr. David C. Pacitti M.B.A.
Industry	Health Technology

Key Management of Avanos Medical, Inc.

Name	Title
Mr. Sigfrido Delgado	Senior Vice President of Operations
Ms. Mojirade James	Senior VP, General Counsel & Corporate Secretary
Mr. Kerr W. Holbrook	Senior VP & Chief Commercial Officer
Mr. David C. Pacitti M.B.A.	CEO & Director
Mr. Scott Galovan	CFO & Senior VP
Ms. Siobhan Smyth	VP & Chief Information Officer
Mr. Jonathan Turner	VP and Chief Ethics & Compliance Officer
Ms. Katrine Kubis	Vice President of Corporate Communications & Community Relations
Ms. Camille Chang Gilmore	SVP & Chief Human Resources Officer
Mr. Lee Burnes	Senior Vice President of Global R&D, Clinical and Medical Affairs

Important FAQs about investing in AVNS Stock from India :

What is Avanos Medical share price today?

Avanos Medical share price today is $11.59 as on August 26, 2025 at 1:29 AM IST. Avanos Medical share today touched a day high of $11.80 and a low of $11.42.

What is the 52 week high and 52 week low for Avanos Medical share?

Avanos Medical share touched a 52 week high of $25.36 and a 52 week low of $9.30. Avanos Medical stock price today i.e. August 26, 2025 at 1:29 AM IST is trending at $11.59, lower by 54.3% versus the 52 week high.

How to invest in Avanos Medical Stock (AVNS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Avanos Medical on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Avanos Medical Shares that will get you 0.1294 shares as per Avanos Medical share price of $11.59 per share as on August 26, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Avanos Medical Stock (AVNS) from India?

Indian investors can start investing in Avanos Medical (AVNS) shares with as little as ₹87.554 or $1 (as of August 26, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.54 in Avanos Medical stock (as per the Rupee-Dollar exchange rate as on August 26, 2025). Based on Avanos Medical share’s latest price of $11.59 as on August 26, 2025 at 1:29 AM IST, you will get 0.8628 shares of Avanos Medical. Learn more about fractional shares .

What are the returns that Avanos Medical has given to Indian investors in the last 5 years?

Avanos Medical stock has given -63.29% share price returns and 18.05% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?